期刊文献+

艰难梭菌二元毒素A的原核表达及免疫原性分析 被引量:1

Prokaryotic expression and immunogenicity analysis of Clostridium difficile binary toxin A
下载PDF
导出
摘要 目的构建艰难梭菌二元毒素(Cdt)A的原核表达载体,表达并纯化His-CdtA重组蛋白,分析其免疫原性。方法以RT 027型艰难梭菌为模板,采用聚合酶链反应(PCR)扩增cdtA的全长序列,导入大肠埃希菌BL21感受态细胞,诱导His-CdtA重组蛋白表达,并用纯化后的蛋白免疫小鼠,分析小鼠产生的抗体效价。结果成功构建pET-28b-cdtA原核表达载体,诱导并纯化出高浓度的His-CdtA重组蛋白,免疫小鼠后产生高效价的抗CdtA抗体。结论纯化的His-CdtA重组蛋白免疫小鼠产生了高效价的抗CdtA抗体,为后续制备抗CdtA单克隆抗体及建立CdtA的实验室检测方法学奠定了基础。 Objective To construct a prokaryotic expression vector of Clostridium difficile binary toxin(Cdt) A,to express and purify His-CdtA recombinant protein,and to analyze its immunogenicity. Methods The fulllength sequence of cdtA was amplified by polymerase chain reaction(PCR) using RT027 Clostridium difficile as template,which was introduced into Escherichia coli BL21 competent cells. The His-CdtA recombinant protein was induced,and the mice were immunized with the purified protein for analyzing the antibodies produced by the mice. Results The prokaryotic expression vector pET-28b-cdtA was successfully constructed,and a high concentration of His-CdtA recombinant protein was induced and purified. After immunizing mice,high-titer antibody of CdtA recombinant protein was produced. Conclusions The mice immunized with the purified His-CdtA recombinant protein produce high-titer anti-CdtA antibodies,which lay a foundation for the subsequent preparation of monoclonal antibodies against CdtA and the methodology of CdtA laboratory detection.
作者 黄颖凤 林雪霏 黄欢欢 吴爱武 HUANG Yingfeng;LIN Xuefei;HUANG Huanhuan;WU Aiwu(KingMed School of Laboratory Medicine of Guangzhou Medical University,Guangzhou 510182,Guangdong,China)
出处 《检验医学》 CAS 2020年第2期159-163,共5页 Laboratory Medicine
基金 广州市科技计划项目(201510010241)
关键词 艰难梭菌 二元毒素A 原核表达 抗体 免疫原性 Clostridium difficile Binary toxin A Prokaryotic expression Antibody Immunogenicity
  • 引文网络
  • 相关文献

参考文献3

二级参考文献44

  • 1胡晓红,刘昕,黄正根,彭惠民,袁科,程英,高云.应用于PCR及实时荧光定量PCR的细菌DNA提取方法[J].第三军医大学学报,2006,28(7):734-735. 被引量:11
  • 2Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis[J]. Nat Rev Mierobiol, 2009, 7(7) : 526 - 536.
  • 3Jangi S, Lamont JT. Asymptomatic colonization by Clostridi- um difficile in infants~ implications for disease in later life [J]. J Pediatr Gastroenterol Nutr, 2010, 51(1): 2-7.
  • 4Rousseau C, Poilane I, De Pontual L, et al. Clostridium dif- ficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains[J]. Clin Infect Dis, 2012, 55 (9): 1209- 1215.
  • 5Mefarland LV. Renewed interest in a difficult disease: Clos- tridium difficile infections epidemiology and current treat ment strategies[J]. Curr Opin Gastroenterol, 2009, 25 ( 1 ) :24 - 35.
  • 6Vedantam G, Clark A, Chu M, et al. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response[J]. Gut Microbes, 2012, 3(2) : 121 - 134.
  • 7Stubbs S, Rupnik M, Gibert M, et al. Production of actin- specific ADP ribosyltransferase (binary toxin) by strains of Clostridium difficile [J].FEMS Microbiol Lett, 2000, 186 (2) : 307 - 312.
  • 8Liao CH, Ko WC, Lu JJ, et al. Characterizations of clinical isolates of Clostridium dffficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin a multicenter study in Taiwan[J]. Antimierob Agents Chemother, 2012, 56(7) : 3943 - 3949.
  • 9Goorhuis A, Bakker D, Corver J, et al. Emergence of Clos- tridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078 [J]. Clin Infect Dis,2008, 47(9): 1162- 1170.
  • 10Mcdonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gen-variant strain of Clostridium difficile [J]. N Engl J Med, 2005, 353(23): 2433-2441.

共引文献8

同被引文献17

引证文献1

;
使用帮助 返回顶部